Why the ChemGenex Pharmaceuticals Limited (CXSP) Has Nearly Doubled
This kind of stock would have been unthinkable just a few years ago. The ADR is for a company from Australia that conducts biotechnology research in the United States. Chinese herbs are the subjects of its prime projects. This is truly a global business. This corporation blends the strengths of three continents into a potentially profitable mix. The early-July 2008 stock price has crossed $19 against a 52-week low of just $8.58. Investor enthusiasm rides on regulatory support for a new company drug to manage a deadly form of blood cancer. Since the molecule has herbal roots, it could work…